Patrick Aisher

Investor at Oxford BioTherapeutics · Angel

Investments

2

Lead Investments

0

Hong Kong, Hong Kong SAR, HK

Highlights

Focus Areas

Biotechnology

Chemical

Innovation Management

SaaS

Software

Firms Invested Under

Recent Investments

Angel Investments

Firm Investments